Alogliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Alogliptin is an oral anti-diabetic drug in the DPP-4 inhibitor (gliptin) class.\u00a0 Note: (see Drugs@FDA for complete indication)<\/p>\n
What is NESINA?\u00a0 \u2022 NESINA is a prescription medicine used along with diet and exercise to improve blood sugar (glucose) control in adults with type 2 diabetes. \u2022 NESINA is unlikely by itself to cause your blood sugar to be lowered to a dangerous level (hypoglycemia). However, hypoglycemia may still occur with NESINA. \u2022 NESINA is not for people with type 1 diabetes. \u2022 NESINA is not for people with diabetic ketoacidosis (increased ketones in blood or urine). It is not known if NESINA is safe and effective in children under the age of 18. Active ingredient: alogliptin Inactive ingredients: mannitol, microcrystalline cellulose, hydroxypropyl cellulose, croscarmellose sodium and magnesium stearate. In addition, the film-coating contains the following inactive ingredients: hypromellose, titanium dioxide, ferric oxide (red or yellow) and polyethylene glycol and is marked with gray F1 printing ink.<\/p>\n
NESINA (alogliptin tablets) for oral use Initial U.S. Approval: 2013
\nTo access alogliptin tablets sold under the brand name can be made available on request to patient if the drug has not been approved or is not available in your country. For information or advice, call IPN’s Pharmaceutical Expert. Our expert will be happy to take your query and guide with an effective solution. Be free and call today for full support at +91 9891 296 838 (Mr. Tarun) \/ +91 9811 747 774 (Mr. Neeraj)<\/p>\n","protected":false},"excerpt":{"rendered":"
NESINA is a dipeptidyl peptidase-4 (DPP-4) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.<\/p>\n
Approval Date: \u00a02013 If you have a prescription from a Registered Medical Practitioner (RMP),\u00a0IPN<\/a> in Delhi can assist you in obtaining access to genuine medication.\u00a0 Our professional will provide you with a step-by-step guide on how to legally and safely import \u201cAlogliptin Tablets\u201d based on the information you provide.<\/strong><\/p>\n
\nProprietary Name: \u00a0NESINA (alogliptin) tablets
\nActive Ingredient(s): \u00a0alogliptin
\nFDA-approved use: type 2 diabetes mellitus
\nDosage Form: \u00a0Tablets: 25 mg, 12.5 mg and 6.25 mg
\nMedicine Approved By: Food and Drug Administration (FDA)
\nManufacturer: Takeda Pharmaceuticals
\nSummary of FDA-approved use on approval date: Click Here<\/a>
\n(see Drugs@FDA for complete indication)<\/p>\nAccess the best support services globally<\/h4>\n